SRNE
Sorrento Therapeutics Inc
Clinical and commercial stage biopharmaceutical company developing treatments for cancer, infectious disease, and pain
CUSIP: 83587F202HealthcareUS1 holder
Sorrento Therapeutics Inc
Clinical and commercial stage biopharmaceutical company developing treatments for cancer, infectious disease, and pain
No financial data available for this security.